Hepatitis E: Historical, contemporary and future perspectives

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue SUPPL. 1, 2011, Pages 72-82

  Aggarwal, Rakesh ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Clinical features; Discovery; Epidemiology; Hepatitis E; History; Prevention; Transmission; Treatment; Vaccine

Indexed keywords

HEPATITIS E VACCINE; IMMUNOSUPPRESSIVE AGENT; RECOMBINANT TRUNCATED CAPSID PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ACUTE ICTERIC HEPATITIS; ANTIBODY RESPONSE; ENDEMIC DISEASE; EPIDEMIOLOGICAL DATA; FUTUROLOGY; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; LIVER CIRRHOSIS; MAMMAL; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; REVIEW; SEROPREVALENCE; SUPERINFECTION; TAXONOMY; VIRUS IDENTIFICATION; VIRUS MORPHOLOGY; VIRUS TRANSMISSION; VIRUS TYPING; WATER CONTAMINATION; WATER SUPPLY;

EID: 78650790355     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06540.x     Document Type: Review

References (102)

1. Schmid R. History of viral hepatitis: a tale of dogmas and misinterpretations. J. Gastroenterol. Hepatol. 2001; 16: 718-22.
2. Cockayne EA. Cattarhal jaundice, sporadic and epidemic, and its relation to acute yellow atrophy of the liver. Q. J. Med. 1912; 6: 1.
3. McCallum FO. Early studies of viral hepatitis. Br. Med. Bull. 1972; 28: 105-8.
4. Feinstone SM, Kapikian AZ, Purcell RH, Alter HJ, Holland PV. Transfusion-associated hepatitis not due to viral hepatitis type A or B. N. Engl. J. Med. 1975; 292: 767-70.
5. Villarejos VM, Visona KA, Eduarte CA, Provost PJ, Hilleman MR. Evidence for viral hepatitis other than type A or type B among persons in Costa Rica. N. Engl. J. Med. 1975; 293: 1350-2.
6. Dienstag JL, Alaama A, Mosley JW, Redeker AG, Purcell RH. Etiology of sporadic hepatitis B surface antigen-negative hepatitis. Ann. Intern. Med. 1977; 87: 1-6.
7. Khuroo MS. Study of an epidemic of non-A, non-B hepatitis: possibility of another human hepatitis virus distinct from post-transfusion non- A, non-B type. Am. J. Med. 1980; 68: 818-23.
8. Wong DC, Purcell RH, Sreenivasan MA, Prasad SR, Pavri KM. Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis etiology. Lancet 1980; 2: 876-9.
9. Vishwanathan R. Infectious hepatitis in Delhi (1955-1956): a critical study: epidemiology. Indian J. Med. Res. 1957; 45 (Suppl. 1): 1-29.
10. Vishwanathan R, Sidhu AS. Infectious hepatitis: clinical findings. Indian J. Med. Res. 1957; 45 (Suppl.): 49-58.
11. Tandon BN, Joshi YK, Jain SK, Gandhi BM, Mathiersen LR, Tandon HD. An epidemic of non-A, non-B hepatitis in north India. Indian J. Med. Res. 1982; 75: 739-44.
12. Kane MA, Bradley DW, Shrestha SM et al. Epidemic non-A, non-B hepatitis in Nepal: recovery of a possible etiologic agent and transmission studies in marmosets. JAMA 1984; 252: 3140-5.
13. Belabbes EH, Bouguermouh A, Benatallah A, Illoul G. Epidemic non-A, non-B viral hepatitis in Algeria: strong evidence for its spreading by water. J. Med. Virol. 1985; 16: 257-63.
14. Anonymous. Enterically transmitted non-A, non-B hepatitis-Mexico. MMWR Morb. Mortal. Wkly. Rep. 1987; 36: 597-602.
15. Velazquez O, Stetler HC, Avila C et al. Epidemic transmission of enterically transmitted non-A, non-B hepatitis in Mexico, 1986-1987. JAMA 1990; 263: 3281-5.
16. Khuroo MS, Deurmeyer W, Zargar SA, Ahanger MA, Shah MA. Acute sporadic non-A, non-B, hepatitis in India. Am. J. Epidemiol. 1983; 118: 360-4.
17. Balayan MS, Andjaparidze AG, Savinskaya SS et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology 1983; 20: 23-31.
18. Bradley DW, Krawczynski K, Cook EH et al. Enterically transmitted non-A, non-B hepatitis: serial passage of disease in cynomolgus macaques and tamarins and recovery of disease-associated 27-34 nm viruslike particles. Proc. Natl. Acad. Sci. U S A 1987; 84: 6277-81.
19. Arankalle VA, Ticehurst J, Sreenivasan MA et al. Aetiological association of a virus like particle with enterically transmitted non-A, non-B hepatitis. Lancet 1988; 1: 550-4.
20. Reyes GR, Purdy MA, Kim JP et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 1990; 247: 1335-9.
21. Tam AW, Smith MM, Guerra ME et al. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 1991; 185: 120-31.
22. Huang CC, Nguyen D, Fernandez J et al. Molecular cloning and sequencing of the Mexico isolate of hepatitis E virus (HEV). Virology 1992; 191: 550-8.
23. Dawson GJ, Chau KH, Cabal CM, Yarbough PO, Reyes GR, Mushahwar IK. Solid-phase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides. J. Virol. Methods 1992; 38: 175-86.
24. Meng XJ, Purcell RH, Halbur PG et al. A novel virus in swine is closely related to the human hepatitis E virus. Proc. Natl. Acad. Sci. U S A 1997; 94: 9860-5.
25. Kwo PY, Schlauder GG, Carpenter HA et al. Acute hepatitis E by a new isolate acquired in the United States. Mayo Clin. Proc. 1997; 72: 1133-6.
26. Schlauder GG, Dawson GJ, Erker JC et al. The sequence and phylogenetic analysis of a novel hepatitis E virus isolated from a patient with acute hepatitis reported in the United States. J. Gen. Virol. 1998; 79: 447-56.
27. Erker JC, Desai SM, Schlauder GG, Dawson GJ, Mushahwar IK. A hepatitis E virus variant from the United States: molecular characterization and transmission in cynomolgus macaques. J. Gen. Virol. 1999; 80: 681-90.
28. Panda SK, Ansari IH, Durgapal H, Agrawal S, Jameel S. The in vitro-synthesized RNA from a cDNA clone of hepatitis E virus is infectious. J. Virol. 2000; 74: 2430-7.
29. Emerson SU, Nguyen H, Graff J, Stephany DA, Brockington A, Purcell RH. In vitro replication of hepatitis E virus (HEV) genomes and of an HEV replicon expressing green fluorescent protein. J. Virol. 2004; 78: 4838-46.
30. Tanaka T, Takahashi M, Kusano E, Okamoto H. Development and evaluation of an efficient cell-culture system for Hepatitis E virus. J. Gen. Virol. 2007; 88: 903-11.
31. Tanaka T, Takahashi M, Takahashi H et al. Development and characterization of a genotype 4 hepatitis E virus cell culture system using a HE-JF5/15F strain recovered from a fulminant hepatitis patient. J. Clin. Microbiol. 2009; 47: 1906-10.
32. Chandra V, Kar-Roy A, Kumari S, Mayor S, Jameel S. The hepatitis E virus ORF3 protein modulates epidermal growth factor receptor trafficking, STAT3 translocation, and the acute-phase response. J. Virol. 2008; 82: 7100-10.
33. Yamashita T, Mori Y, Miyazaki N et al. Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure. Proc. Natl. Acad. Sci. U S A 2009; 106: 12986-91.
34. Guu TS, Liu Z, Ye Q et al. Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding. Proc. Natl. Acad. Sci. U S A 2009; 106: 12992-7.
35. Li TC, Takeda N, Miyamura T et al. Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus. J. Virol. 2005; 79: 12999-3006.
36. Lu L, Li C, Hagedorn CH. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev. Med. Virol. 2006; 16: 5-36.
37. Payne CJ, Ellis TM, Plant SL, Gregory AR, Wilcox GE. Sequence data suggests big liver and spleen disease virus (BLSV) is genetically related to hepatitis E virus. Vet. Microbiol. 1999; 68: 119-25.
38. Huang FF, Haqshenas G, Shivaprasad HL et al. Heterogeneity and seroprevalence of a newly identified avian hepatitis E virus from chickens in the United States. J. Clin. Microbiol. 2002; 40: 4197-202.
39. Sun ZF, Larsen CT, Huang FF et al. Generation and infectivity titration of an infectious stock of avian hepatitis E virus (HEV) in chickens and cross-species infection of turkeys with avian HEV. J. Clin. Microbiol. 2004; 42: 2658-62.
40. van Cuyck-Gandre H, Zhang HY, Tsarev SA et al. Characterization of hepatitis E virus (HEV) from Algeria and Chad by partial genome sequence. J. Med. Virol. 1997; 53: 340-7.
41. Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect. Dis. 2008; 8: 698-709.
42. Wang Y, Ling R, Erker JC et al. A divergent genotype of hepatitis E virus in Chinese patients with acute hepatitis. J. Gen. Virol. 1999; 80: 169-77.
43. Guo H, Zhou EM, Sun ZF, Meng XJ, Halbur PG. Identification of B-cell epitopes in the capsid protein of avian hepatitis E virus (avian HEV) that are common to human and swine HEVs or unique to avian HEV. J. Gen. Virol. 2006; 87: 217-23.
44. Meng XJ. Hepatitis E virus: animal reservoirs and zoonotic risk. Vet. Microbiol. 2010; 140: 256-65.
45. Pina S, Buti M, Cotrina M, Piella J, Girones R. HEV identified in serum from humans with acute hepatitis and in sewage of animal origin in Spain. J. Hepatol. 2000; 33: 826-33.
46. Wu JC, Chen CM, Chiang TY et al. Clinical and epidemiological implications of swine hepatitis E virus infection. J. Med. Virol. 2000; 60: 166-71.
47. Takahashi K, Kang JH, Ohnishi S et al. Full-length sequences of six hepatitis E virus isolates of genotypes III and IV from patients with sporadic acute or fulminant hepatitis in Japan. Intervirology 2003; 46: 308-18.
48. Arankalle VA, Chobe LP, Joshi MV, Chadha MS, Kundu B, Walimbe AM. Human and swine hepatitis E viruses from Western India belong to different genotypes. J. Hepatol. 2002; 36: 417-25.
49. Shukla P, Chauhan UK, Naik S, Anderson D, Aggarwal R. Hepatitis E virus infection among animals in northern India: an unlikely source of human disease. J. Viral Hepat. 2007; 14: 310-7.
50. Rolfe KJ, Curran MD, Mangrolia N et al. First case of genotype 4 human hepatitis E virus infection acquired in India. J. Clin. Virol. 2010; 48: 58-61.
51. Tei S, Kitajima N, Takahashi K, Mishiro S. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet 2003; 362: 371-3.
52. Sonoda H, Abe M, Sugimoto T et al. Prevalence of hepatitis E virus (HEV) Infection in wild boars and deer and genetic identification of a genotype 3 HEV from a boar in Japan. J. Clin. Microbiol. 2004; 42: 5371-4.
53. Zhao C, Ma Z, Harrison TJ et al. A novel genotype of hepatitis E virus prevalent among farmed rabbits in China. J. Med. Virol. 2009; 81: 1371-9.
54. Nakamura M, Takahashi K, Taira K et al. Hepatitis E virus infection in wild mongooses of Okinawa, Japan: demonstration of anti-HEV antibodies and a full-genome nucleotide sequence. Hepatol. Res. 2006; 34: 137-40.
55. Johne R, Plenge-Bonig A, Hess M, Ulrich RG, Reetz J, Schielke A. Detection of a novel hepatitis E-like virus in faeces of wild rats using a nested broad-spectrum RT-PCR. J. Gen. Virol. 2010; 91: 750-8.
56. Hu GD, Ma X. Detection and sequences analysis of bovine hepatitis E virus RNA in Xinjiang Autonomous Region. Bing Du Xue Bao. 2010; 26: 27-32.
57. Meng XJ, Halbur PG, Shapiro MS et al. Genetic and experimental evidence for cross-species infection by swine hepatitis E virus. J. Virol. 1998; 72: 9714-21.
58. Arankalle VA, Chobe LP, Chadha MS. Type-IV Indian swine HEV infects rhesus monkeys. J. Viral Hepat. 2006; 13: 742-5.
59. Meng XJ, Halbur PG, Haynes JS et al. Experimental infection of pigs with the newly identified swine hepatitis E virus (swine HEV), but not with human strains of HEV. Arch. Virol. 1998; 143: 1405-15.
60. Mizuo H, Yazaki Y, Sugawara K et al. Possible risk factors for the transmission of hepatitis E virus and for the severe form of hepatitis E acquired locally in Hokkaido, Japan. J. Med. Virol. 2005; 76: 341-9.
61. Naik SR, Aggarwal R, Salunke PN, Mehrotra NN. A large waterborne viral hepatitis E epidemic in Kanpur, India. Bull. World Health Organ. 1992; 70: 597-604.
62. Zhuang H, Cao X-Y, Liu C-B, Wang G-M. Enterically transmitted non-A, non-B hepatitis in China. In: Shikata T, Purcell RH, Uchida T, eds. Viral Hepatitis C, D and E. Amsterdam: Excerpta Medica, 1991; 277-85.
63. Corwin AL, Tien NT, Bounlu K et al. The unique riverine ecology of hepatitis E virus transmission in South-East Asia. Trans. R. Soc. Trop. Med. Hyg. 1999; 93: 255-60.
64. Sailaja B, Murhekar MV, Hutin YJ et al. Outbreak of waterborne hepatitis E in Hyderabad, India, 2005. Epidemiol. Infect. 2009; 137: 234-40.
65. Teshale EH, Howard CM, Grytdal SP et al. Hepatitis E epidemic, Uganda. Emerg. Infect. Dis. 2010; 16: 126-9.
66. Bhatia V, Singhal A, Panda SK, Acharya SK. A 20-year single-center experience with acute liver failure during pregnancy: is the prognosis really worse? Hepatology 2008; 48: 1577-85.
67. Pal R, Aggarwal R, Naik SR, Das V, Das S, Naik S. Immunological alterations in pregnant women with acute hepatitis E. J. Gastroenterol. Hepatol. 2005; 20: 1094-101.
68. Navaneethan U, Al Mohajer M, Shata MT. Hepatitis E and pregnancy: understanding the pathogenesis. Liver Int. 2008; 28: 1190-9.
69. Kar P, Jilani N, Husain SA et al. Does hepatitis E viral load and genotypes influence the final outcome of acute liver failure during pregnancy? Am. J. Gastroenterol. 2008; 103: 2495-501.
70. Ippagunta SK, Naik S, Sharma B, Aggarwal R. Presence of hepatitis E virus in sewage in Northern India: frequency and seasonal pattern. J. Med. Virol. 2007; 79: 1827-31.
71. Aggarwal R, Naik SR. Hepatitis E: does person-to-person spread occur? Indian J. Gastroenterol. 1992; 11: 109-12.
72. Somani SK, Aggarwal R, Naik SR, Srivastava S, Naik S. A serological study of intrafamilial spread from patients with sporadic hepatitis E virus infection. J. Viral Hepat. 2003; 10: 446-9.
73. Khuroo MS, Kamili S, Jameel S. Vertical transmission of hepatitis E virus. Lancet 1995; 345: 1025-6.
74. Khuroo MS, Kamili S, Yattoo GN. Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J. Gastroenterol. Hepatol. 2004; 19: 778-84.
75. Dalton HR, Stableforth W, Thurairajah P et al. Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur. J. Gastroenterol. Hepatol. 2008; 20: 784-90.
76. Ijaz S, Arnold E, Banks M et al. Non-travel-associated hepatitis E in England and wales: demographic, clinical, and molecular epidemiological characteristics. J. Infect. Dis. 2005; 192: 1166-72.
77. Takahashi K, Kitajima N, Abe N, Mishiro S. Complete or near-complete nucleotide sequences of hepatitis E virus genome recovered from a wild boar, a deer, and four patients who ate the deer. Virology 2004; 330: 501-5.
78. Feagins AR, Opriessnig T, Guenette DK, Halbur PG, Meng XJ. Detection and characterization of infectious Hepatitis E virus from commercial pig livers sold in local grocery stores in the USA. J. Gen. Virol. 2007; 88: 912-7.
79. Yazaki Y, Mizuo H, Takahashi M et al. Sporadic acute or fulminant hepatitis E in Hokkaido, Japan, may be food-borne, as suggested by the presence of hepatitis E virus in pig liver as food. J. Gen. Virol. 2003; 84: 2351-7.
80. Aggarwal R, Kini D, Sofat S, Naik SR, Krawczynski K. Duration of viraemia and faecal viral excretion in acute hepatitis E. Lancet 2000; 356: 1081-2.
81. Aggarwal R, Kamili S, Spelbring J, Krawczynski K. Experimental studies on subclinical hepatitis E virus infection in cynomolgus macaques. J. Infect. Dis. 2001; 184: 1380-5.
82. Mast EE, Alter MJ, Holland PV, Purcell RH. Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E Virus Antibody Serum Panel Evaluation Group. Hepatology 1998; 27: 857-61.
83. Khuroo MS, Kamili S, Dar MY, Moecklii R, Jameel S. Hepatitis E and long-term antibody status. Lancet 1993; 341: 1355.
84. Myint KS, Endy TP, Shrestha MP et al. Hepatitis E antibody kinetics in Nepalese patients. Trans. R. Soc. Trop. Med. Hyg. 2006; 100: 938-41.
85. Arankalle VA, Tsarev SA, Chadha MS et al. Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J. Infect. Dis. 1995; 171: 447-50.
86. Stoszek SK, Engle RE, Abdel-Hamid M et al. Hepatitis E antibody seroconversion without disease in highly endemic rural Egyptian communities. Trans. R. Soc. Trop. Med. Hyg. 2006; 100: 89-94.
87. Kuniholm MH, Purcell RH, McQuillan GM, Engle RE, Wasley A, Nelson KE. Epidemilogy of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survery, 1988-1994. J. Infect. Dis. 2009; 200: 48-56.
88. Kumar A, Aggarwal R, Naik SR, Saraswat V, Ghoshal UC, Naik S. Hepatitis E virus is responsible for decompensation of chronic liver disease in an endemic region. Indian J. Gastroenterol. 2004; 23: 59-62.
89. Borgen K, Herremans T, Duizer E et al. Non-travel related Hepatitis E virus genotype 3 infections in the Netherlands; a case series 2004-2006. BMC Infect. Dis. 2008; 8: 61.
90. Mansuy JM, Peron JM, Abravanel F et al. Hepatitis E in the south west of France in individuals who have never visited an endemic area. J. Med. Virol. 2004; 74: 419-24.
91. Dalton HR, Fellows HJ, Stableforth W et al. The role of hepatitis E virus testing in drug-induced liver injury. Aliment. Pharmacol. Ther. 2007; 26: 1429-35.
92. Kamar N, Selves J, Mansuy JM et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N. Engl. J. Med. 2008; 358: 811-7.
93. Gerolami R, Moal V, Colson P. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N. Engl. J. Med. 2008; 358: 859-60.
94. Mallet V, Nicand E, Sultanik P et al. Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann. Intern. Med. 2010; 153: 85-9.
95. Kamar N, Rostaing L, Abravanel F et al. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin. Infect. Dis. 2010; 50: e30-3.
96. Kamili S, Spelbring J, Carson D, Krawczynski K. Protective efficacy of hepatitis E virus DNA vaccine administered by gene gun in the cynomolgus macaque model of infection. J. Infect. Dis. 2004; 189: 258-64.
97. Purcell RH, Nguyen H, Shapiro M et al. Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine. Vaccine 2003; 21: 2607-15.
98. Shrestha MP, Scott RM, Joshi DM et al. Safety and efficacy of a recombinant hepatitis E vaccine. N. Engl. J. Med. 2007; 356: 895-903.
99. Li SW, Zhang J, Li YM et al. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine 2005; 23: 2893-901.
100. Zhang J, Liu CB, Li RC et al. Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine. Vaccine 2009; 27: 1869-74.
101. Zhu FC, Zhang J, Zhang XF et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010; 376: 895-902.
102. Wahi PN, Arora MM. Epidemic hepatitis. N. Engl. J. Med. 1953; 248: 451-4.